"Modern Endovascular Therapy".
Journal
World journal of surgery
ISSN: 1432-2323
Titre abrégé: World J Surg
Pays: United States
ID NLM: 7704052
Informations de publication
Date de publication:
Dec 2021
Dec 2021
Historique:
accepted:
31
10
2020
pubmed:
24
11
2020
medline:
1
2
2022
entrez:
23
11
2020
Statut:
ppublish
Résumé
The past 25 years have been witness to a revolution in how vascular care is delivered. The majority of arterial and venous interventions have converted from open surgery to minimally invasive percutaneous endovascular procedures. This surgical innovations symposium article reviews current endovascular therapy in multiple vascular beds with a primary focus on carotid artery occlusive disease, aortic pathologies, and lower extremity arterial occlusive disease. Mesenteric arterial occlusive disease and lower extremity venous endovascular therapies are also briefly discussed. Indications for intervention, treatment examples and outcomes analysis are presented. While not reviewed in this article, endovascular therapy has also become first line in the treatment of coronary artery disease, chronic mesenteric arterial occlusive disease, superficial venous reflux, central vein occlusion, and acute venous thrombus intervention when indicated. Endovascular therapies are used in all vascular beds to treat the full spectrum of vascular pathologies. Aneurysm disease, atherosclerotic arterial occlusive disease, acute arterial and venous thrombosis, ongoing hemorrhage, and venous reflux are among the issues which can be addressed by endovascular means. The minimally invasive nature of endovascular treatments in what is largely a very co-morbid patient cohort is an attractive method of avoiding major procedural related morbidity and mortality.
Identifiants
pubmed: 33225390
doi: 10.1007/s00268-020-05875-7
pii: 10.1007/s00268-020-05875-7
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
3493-3502Informations de copyright
© 2020. Société Internationale de Chirurgie.
Références
North American Symptomatic Carotid Endarterectomy Trial Collaborators, Barnett HJM, Taylor DW, et al. (1991) Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 325(7): 445‐453
Moore WS, Young B, Baker WH, Robertson JT, Toole JF, Vescera CL, Howard VJ (1996) Surgical results: a justification of the surgeon selection process for the ACAS trial. ACAS Investig J Vasc Surg 23(2):323–328
Yadav JS, Wholey MH, Kuntz RE, Fayad P, Katzen BT, Mishkel GJ et al (2004) Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 351:1493–1501
pubmed: 15470212
Brott TG, Hobson RW 2nd, Howard G, Roubin GS, Clark WM, Brooks W, Mackey A, Hill MD, Leimgruber PP, Sheffet AJ, Howard VJ, Moore WS, Voeks JH, Hopkins LN, Cutlip DE, Cohen DJ, Popma JJ, Ferguson RD, Cohen SN, Blackshear JL, Silver FL, Mohr JP, Lal BK, Meschia JF; CREST Investigators (2010) Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med. 363(1): 11–23
Sabat J, Bock D, Hsu CH, Tan TW, Weinkauf C, Trouard T, Perez-Carrillo GG, Zhou W (2020) Risk factors associated with microembolization after carotid intervention. J Vasc Surg 71(5):1572–1578
pubmed: 31493967
Brott TG, Howard G, Roubin GS, Meschia JF, Mackey A, Brooks W, Moore WS, Hill MD, Mantese VA, Clark WM, Timaran CH, Heck D, Leimgruber PP, Sheffet AJ, Howard VJ, Chaturvedi S, Lal BK
Schermerhorn ML, Liang P, Eldrup-Jorgensen J, Cronenwett JL, Nolan BW, Kashyap VS et al (2019) Association of transcarotid artery revascularization vs transfemoral carotid artery stenting with stroke or death among patients with carotid artery stenosis. JAMA 322:2313–2322
pubmed: 31846015
pmcid: 6990823
Howard VJ, Meschia JF, Lal BK, Turan TN, Roubin GS, Brown RD Jr, Voeks JH, Barrett KM, Demaerschalk BM, Huston J, Lazar RM, Moore WS, Wadley VG, Chaturvedi S, Moy CS, Chimowitz M, Howard G, Brott TG (2017) Carotid revascularization and medical management for asymptomatic carotid stenosis: protocol of the CREST-clinical trials CREST- study investigators. Int J Stroke 12(7):770–778
pubmed: 28462683
pmcid: 5987521
Parodi JC, Palmaz JC, Barone HD (1991) Transfemoral intraluminal graft implantation for abdominal aortic aneurysms. Ann Vasc Surg 5:491–499
pubmed: 1837729
Buck DB, Karthaus EG, Soden PA, Ultee KHJ, Van Herwaarden JA, Moll FL et al (2015) Percutaneous versus femoral cutdown access for endovascular aneurysm repair. J Vasc Surg 62:16–21
pubmed: 25827969
pmcid: 4484310
Columbo JA, Ramkumar N, Martinez-Camblor P, Kang R, Suckow BD, NO’Malley AJ, Sedrakyan A, Goodney PP (2020) Five-year reintervention after endovascular abdominal aortic aneurysm repair in the vascular quality initiative. J Vasc Surg 71(3):799–805
pubmed: 31471231
Faries PL, Cadot H, Agarwal G, Craig Kent K, Hollier LH, Marin ML (2003) Management of endoleak after endovascular aneurysm repair: Cuffs, coils, and conversion. J Vasc Surg 37:1155–61
pubmed: 12764258
Rayt HS, Sandford RM, Salem M, Bown MJ, London NJ, Sayers RD (2009) Conservative management of type 2 endoleaks is not associated with increased risk of aneurysm rupture. J Vasc Surg 50(6):1529–1530
Stavropoulos SW, Park J, Fairman R, Carpenter J (2009) Type 2 endoleak embolization comparison: translumbar embolization versus modified transarterial embolization. J Vasc Interv Radiol 20:1299–1302
pubmed: 19695902
Thomas WR, Karkhanis S, Hopkins J, Duddy M (2020) Translumbar embolization of type ii endoleaks: 12 years of experience at a regional vascular centre. Vasc Endovascular Surg 13:1538574420918972
Scali ST, Vlada A, Chang CK, Beck AW (2013) Transcaval embolization as an alternative technique for the treatment of type II endoleak after endovascular aortic aneurysm repair. J Vasc Surg 57(3):869–874
pubmed: 23312838
pmcid: 4059016
Schermerhorn ML, Buck DB, O’Malley AJ, Curran T, McCallum JC, Darling J et al (2015) Long-term outcomes of abdominal aortic aneurysm in the medicare population. N Engl J Med 373:328–338
pubmed: 26200979
pmcid: 4532303
Patel R, Sweeting MJ, Powell JT, Greenhalgh RM (2016) Endovascular versus open repair of abdominal aortic aneurysm in 15-years’ follow-up of the UK endovascular aneurysm repair trial 1 (EVAR trial 1): a randomised controlled trial. Lancet 388:2366–2374
pubmed: 27743617
Lederle FA, Kyriakides TC, Stroupe KT, Freischlag JA, Padberg FT Jr, Matsumura JS, Huo Z, Johnson GR (2019) OVER veterans affairs cooperative study group. “open versus endovascualr repair of abdominal aortic aneurysm.” N Engl J Med 380(22):2126–2135
pubmed: 31141634
van Schaik TG, Yeung KK, Verhagen HJ, de Bruin JL, van Sambeek MRHM, Balm R, Zeebregts CJ, van Herwaarden JA, Blankensteijn JD (2017) DREAM trial participants “Long-term survival and secondary procedures after open or endovascular repair of abdominal aortic aneurysms.” J Vasc Surg 66(5):1379–1389
pubmed: 29061270
Dua A, Kuy S, Lee CJ, Upchurch GR, Desai SS (2014) Epidemiology of aortic aneurysm repair in the United States from 2000 to 2010. J Vasc Surg 59:1512–1517
pubmed: 24560865
Dake MD (2001) Endovascular stent-graft management of thoracic aortic diseases. Eur J Radiol 39:42–49
pubmed: 11439230
Fattori R, Montgomery D, Lovato L, Kische S, Di Eusanio M, Ince H, Eagle KA, Isselbacher EM, Nienaber CA (2013) JACC Cardiovasc Interv 6(8):876–82
pubmed: 23968705
Abel D, Morales JP (2011) Food and Drug Administration commentary on the SVS masterfile for acute complicated type B aortic dissections and transections. J Vasc Surg 53:1079–1081
pubmed: 21439458
Nienaber CA, Kische S, Zeller T, Rehders TC, Schneider H, Lorenzen B et al (2006) Provisional extension to induce complete attachment after stent-graft placement in type B aortic dissection: the PETTICOAT concept. J Endovasc Ther 13:738–746
pubmed: 17154712
Konstantinou N, Debus ES, Vermeulen C, Wipper S, Diener H, Larena-Avellaneda A et al (2019) Cervical debranching in the endovascular era: a single-center experience. Eur J Vasc Endovasc Surg 58:34–40
pubmed: 31204185
Arnaoutakis DJ, Scali ST, Beck AW, Kubilis P, Huber TS, Martin AJ, Laquian L, Back M, Giles KA, Fatima J, Beaver TM, Upchurch GR Jr (2020) Comparative outcomes of open, hybrid, and fenestrated branched endovascular repair of extent II and III thoracoabdominal aortic aneurysms. J Vasc Surg 71:1503–14
pubmed: 31727462
Tsilimparis N, Law Y, Rohlffs F, Spanos K, Debus ES, Kölbel T (2020) Fenestrated endovascular repair for diseases involving the aortic arch. J Vasc Surg 71:1464–71
pubmed: 32063444
Motta F, Vallabhaneni R, Kalbaugh CA, Alyateem G, Marston WA, Farber MA (2019) Comparison of commercially available versus customized branched-fenestrated devices in the treatment of complex aortic aneurysms. J Vasc Surg 69(3):645–650
pubmed: 30126783
Pearce BJ, Scali ST, Beck AW (2017) The role of surgeon modified fenestrated stent grafts in the treatment of aneurysms involving the branched visceral aorta. J Cardiovasc Surg (Torino) 58:861–869
Della Schiava N, Arsicot M, Boudjelit T, Feugier P, Lermusiaux P, Millon A (2016) “Conformability of GORE excluder iliac branch endoprosthesis and COOK zenith bifurcated iliac side branched iliac stent grafts.” Ann Vasc Surg 36:139–144
pubmed: 27395814
Zhu J, Dai X, Noiniyom P, Luo Y, Fan H, Feng Z et al (2019) Fenestrated thoracic endovascular aortic repair using physician-modified stent grafts (PMSGs) in Zone 0 and zone 1 for aortic arch diseases. Cardiovasc Intervent Radiol 42:19–27
pubmed: 30327926
Schwierz E, Kolvenbach RR, Yoshida R, Yoshida W, Alpaslan A, Karmeli R (2014) Experience with the sandwich technique in endovascular thoracoabdominal aortic aneurysm repair. J Vasc Surg 59:1562–1569
pubmed: 24613690
GT Taneva, FJ Criado, G Torsello, F Veith, ST Scali, P Kubilis, and KP Donas, on behalf of the PERICLES collaborators (2020) “Results of chimney endovascular aneurysm repair as used in the PERICLES Registry to treat patients with suprarenal aortic pathologies”. J Vasc Surg 71: 1521–1527
Abu Dabrh AM, Steffen MW, Asi N, Undavalli C, Wang Z, Elamin MB et al (2016) Bypass surgery versus endovascular interventions in severe or critical limb ischemia. J Vasc Surg 63:244–253
pubmed: 26372187
Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG (2007) Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 45(Suppl S):S5-67
pubmed: 17223489
Siracuse JJ, Menard MT, Eslami MH, Kalish JA, Robinson WP, Eberhardt RT et al (2016) Comparison of open and endovascular treatment of patients with critical limb ischemia in the vascular quality initiative. J Vasc Surg 63(958–965):e1
Bradbury AW, Adam DJ, Bell J, Forbes JF, Fowkes FG, Gillespie I et al (2010) Bypass versus angioplasty in Severe Ischaemia of the Leg (BASIL) trial: analysis of amputation free and overall survival by treatment received. J Vasc Surg 51(Suppl):18S-31S
pubmed: 20435259
Michael S. Conte, MD, Andrew W. Bradbury, MD, Philippe Kolh, MD (Co-Editor), John V. White, MD (Steering Committee), Florian Dick, MD (Steering Committee), Robert Fitridge, MBBS (Steering Committee), Joseph L. Mills, MD (Steering Committee), Jean-Baptiste Ricco, MD (Steering Committee), Kalkunte R. Suresh, MD (Steering Committee), M. Hassan Murad, MD, MPH, and the GVG Writing Group (2019) “Global vascular guidelines on the management of chronic limb-threatening ischemia” J Vasc Surg 69: 3S-125S
DeRubertis BG, Pierce M, Chaer RA, Rhee SJ, Benjeloun R, Ryer EJ et al (2007) Lesion severity and treatment complexity are associated with outcome after percutaneous infra-inguinal intervention. J Vasc Surg 46:709–716
pubmed: 17903651
Chang RW, Goodney PP, Baek JH, Nolan BW, Rzucidlo EM, Powell RJ (2008) Long-term results of combined common femoral endarterectomy and iliac stenting/stent grafting for occlusive disease. J Vasc Surg 48:362–367
pubmed: 18572359
Schneider PA, Caps MT, Ogawa DY, Hayman ES (2001) Intraoperative superficial femoral artery balloon angioplasty and popliteal to distal bypass graft: an option for combined open and endovascular treatment of diabetic gangrene. J Vasc Surg 33:955–962
pubmed: 11331834
Gandini R, Del Giudice C, Simonetti G (2014) Pedal and plantar loop angioplasty: technique and results. J Cardiovasc Surg (Torino) 55:665–670
Shammas NW, Lam R, Mustapha J, Ellichman J, Aggarwala G, Rivera E et al (2012) Comparison of orbital atherectomy plus balloon angioplasty vs. balloon angioplasty alone in patients with critical limb ischemia: results of the CALCIUM 360 randomized pilot trial. J Endovasc Ther 19:480–8
pubmed: 22891826
Zeller T, Baumgartner I, Scheinert D, Brodmann M, Bosiers M, Micari A et al (2014) Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial. J Am Coll Cardiol 64:1568–76
pubmed: 25301459
Setacci C, Chisci E, de Donato G, Setacci F, Iacoponi F, Galzerano G (2009) Subintimal angioplasty with the aid of a re-entry device for TASC C and D lesions of the SFA. Eur J Vasc Endovasc Surg 38:76–87
pubmed: 19427245
Dake MD, Ansel GM, Jaff MR, Ohki T, Saxon RR, Smouse HB et al (2011) Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results. Circ Cardiovasc Interv 4:495–504
pubmed: 21953370
Bekken J, Jongsma H, Ayez N, Hoogewerf CJ, Van Weel V, Fioole B (2015) Angioplasty versus stenting for iliac artery lesions. Cochrane Database Syst Rev (5): CD007561
Almasri J, Adusumalli J, Asi N, Lakis S, Alsawas M, Prokop LJ et al (2018) A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia. J Vasc Surg 68:624–633
pubmed: 29804736
Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W et al (2006) Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 354:1879–1888
pubmed: 16672699
Saxon RR, Dake MD, Volgelzang RL, Katzen BT, Becker GJ (2008) Randomized, multicenter study comparing expanded polytetrafluoroethylene-covered endoprosthesis placement with percutaneous transluminal angioplasty in the treatment of superficial femoral artery occlusive disease. J Vasc Interv Radiol 19:823–832
pubmed: 18503895
Dosluoglu HH, Cherr GS, Lall P, Harris LM, Dryjski ML (2008) Stenting vs above knee polytetrafluoroethylene bypass for transatlantic inter-society consensus-II C and D superficial femoral artery disease. J Vasc Surg 48:1166–1174
pubmed: 18692357
Rosenfield K, Jaff MR, White CJ, Rocha-Singh K, MenaHurtado C, Metzger DC et al (2015) Trial of a paclitaxel-coated balloon for femoropopliteal artery disease. N Engl J Med 373:145–153
pubmed: 26106946
Katsanos K, Spiliopoulos S, Kitrou P, Krokidis M, Karnabatidis D (2018) Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials. J American Heart Assoc 7(24):e011245
Geraghty PJ, Mewissen WM, Jaff MR, Ansel GM (2013) Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease. J Vasc Surg 58:386–95
pubmed: 23676191
Liistro F, Porto I, Angioli P, Grotti S, Ricci L, Ducci K et al (2013) Drug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK): a randomized trial in diabetic patients with critical limb ischemia. Circulation 128(615–21):393
Todd KE, Ahanchi SS, Maurer CA, Kim JH, Chipman CR, Panneton JM (2013) Atherectomy offers no benefits over balloon angioplasty in tibial interventions for critical limb ischemia. J Vasc Surg 58:941–948
pubmed: 23755978
Ambler GK, Radwan R, Hayes PD, Twine CP (2014) Atherectomy for peripheral arterial disease. Cochrane Database Syst Rev 3:CD006680
Baumann F, Bloesch S, Engelberger RP, Makaloski V, Fink H, Do DD et al (2013) Clinically-driven need for secondary interventions after endovascular revascularization of tibial arteries in patients with critical limb ischemia. J Endovasc Ther 20:707–713
pubmed: 24093325
Lo RC, Darling J, Bensley RP, Giles KA, Dahlberg SE, Hamdan AD et al (2013) Outcomes following infrapopliteal angioplasty for critical limb ischemia. J Vasc Surg 57:1455–1464
pubmed: 23375610
pmcid: 3644532
Saqib NU, Domenick N, Cho JS, Marone L, Leers S, Makaroun MS et al (2013) Predictors and outcomes of restenosis following tibial artery endovascular interventions for critical limb ischemia. J Vasc Surg 57:692–699
pubmed: 23351646
Bosiers M, Kallakuri S, Deloose K, Verbist J, Peeters P (2008) Infragenicular angioplasty and stenting in the management of critical limb ischaemia: one year outcome following the use of the MULTI-LINK VISION stent. EuroIntervention 3:470–474
pubmed: 19736090
Giles KA, Pomposelli FB, Hamdan AD, Blattman SB, Panossian H, Schermerhorn ML (2008) Infrapopliteal angioplasty for critical limb ischemia: relation of transatlantic intersociety consensus class to outcome in 176 limbs. J Vasc Surg 48:128–136
pubmed: 18502084
Baril DT, Rhee RY, Kim J, Makaroun MS, Chaer RA, Marone LK (2009) Duplex criteria for determination of in-stent stenosis after angioplasty and stenting of the superficial femoral artery. J Vasc Surg 49:133–139
pubmed: 19174252
Kwolek C, Shuma F (2014) “Acute ischemia” rutherford’s vascular surgery, 8th edn. Elsevier Publishing, Amsterdam, pp 2528–2543